UHPLC-MS/MS method for pharmacokinetic and bioavailability determination of five bioactive components in raw and various processed products of Polygala tenuifolia in rat plasma

摘要

Context Sibiricose A5 (A5), sibiricose A6 (A6), 3,6′-disinapoyl sucrose (DSS), tenuifoliside A (TFSA) and 3,4,5-trimethoxycinnamic acid (TMCA) are the main active components of Polygala tenuifolia Willd. (Polygalaceae) (PT) that are active against Alzheimer's disease. Objective To compare the pharmacokinetics and bioavailability of five active components in the roots of raw PT (RPT), liquorice-boiled PT (LPT) and honey-stir-baked PT (HPT). Materials and methods The median lethal dose (LD50) was evaluated through acute toxicity test. The pharmacokinetics of five components after oral administration of extracts of RPT, LPT, HPT (all equivalent to 1.9?g/kg of RPT extract for one dose) and 0.5% CMC-Na solution (control group) were investigated, respectively, in Sprague-Dawley rats (four groups, n?=?6) using UHPLC-MS/MS. In addition, the absolute bioavailability of A5, A6, DSS, TFSA and TMCA after oral administration (7.40, 11.60, 16.00, 50.00 and 3.11?mg/kg, respectively) and intravenous injection (1/10 of the corresponding oral dose) in rats (n?=?6) was studied. Results The LD50 of RPT, LPT and HPT was 7.79, 14.55 and 15.99?g/kg, respectively. AUC 0- t of RPT, LPT and HPT were as follows: A5 (433.18?±?65.48, 680.40?±?89.21, 552.02?±?31.10?ng h/mL), A6 (314.55?±?62.73, 545.76?±?123.16, 570.06?±?178.93?ng h/mL) and DSS (100.30?±?62.44, 232.00?±?66.08, 197.58?±?57.37?ng h/mL). The absolute bioavailability of A5, A6, DSS, TFSA and TMCA was 3.25, 2.95, 2.36, 1.17 and 42.91%, respectively. Discussion and conclusions The pharmacokinetic and bioavailability parameters of each compound can facilitate future clinical studies.